76 related articles for article (PubMed ID: 354762)
1. Immunologic detection of primary carcinoma of the pancreas.
Taguchi K
Can J Surg; 1978 Jul; 21(4):313-5. PubMed ID: 354762
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte adherence inhibition assay to detect primary cancer of the pancreas.
Taguchi K
Surg Forum; 1977; 28():123-5. PubMed ID: 364711
[No Abstract] [Full Text] [Related]
3. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
[No Abstract] [Full Text] [Related]
5. Early diagnosis of cancers of colon, pancreas, stomach, and lung by automated tube leukocyte adherence inhibition assay.
Tataryn DN; MacFarlane JK; Thomson DM
Surg Forum; 1978; 29():130-2. PubMed ID: 401404
[No Abstract] [Full Text] [Related]
6. [Specific immunity in patients with carcinoma of the pancreas. Preliminary report].
Mester M; Zuliani A; Scheinberg MA; Machado MC
Rev Hosp Clin Fac Med Sao Paulo; 1983 Jun; 38(3):107-10. PubMed ID: 6364296
[No Abstract] [Full Text] [Related]
7. Evaluation of the microleukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer.
Russo AJ; Douglass HO; Leveson SH; Howell JH; Holyoke ED; Harvey SR; Chu TM; Goldrosen MH
Cancer Res; 1978 Jul; 38(7):2023-9. PubMed ID: 77724
[No Abstract] [Full Text] [Related]
8. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
9. [The L.A.I. test and tumor markers (Ca 19-9 and TPA) in the diagnosis of pancreatic carcinoma].
Meduri F; Bizzarini M; Diana F; Merenda R; Gerunda GE; Doni MG; Maffei Faccioli A
Minerva Chir; 1989 Aug; 44(15-16):1777-81. PubMed ID: 2682370
[TBL] [Abstract][Full Text] [Related]
10. [Screening for colorectal neoplasms].
Shani A; Rozen P; Fink A; Bass D; Levy E; Fireman Z; Gottesfeld F; Baker S; Fraizer D; Bentwich Z
Harefuah; 1990 Jan; 118(2):66-70. PubMed ID: 2179072
[TBL] [Abstract][Full Text] [Related]
11. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
12. [Leukocyte adhesion inhibition to glass (LAI test) and early diagnosis of pancreatic carcinoma].
Meduri F; Bizzarini M; Diana F; Gerunda G; Maffei-Faccioli A
Minerva Chir; 1986 Aug; 41(15-16):1283-8. PubMed ID: 3774173
[No Abstract] [Full Text] [Related]
13. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
14. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
Goldrosen MH; Howell JH; Holyoke ED
Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
[TBL] [Abstract][Full Text] [Related]
16. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
[TBL] [Abstract][Full Text] [Related]
17. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
18. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
19. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
Tannenbaum H; Wild J
Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
[TBL] [Abstract][Full Text] [Related]
20. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
